Ro 41-5253

Names

[ Name ]:
Ro 41-5253

[Synonym ]:
LG-629
Ro 41-5253

Biological Activity

[Description]:

Ro 41-5253 is an orally active selective retinoic acid receptor alpha (RARα) antagonist. Ro 41-5253 can bind RARα without inducing transcription or affecting RAR/RXR heterodimerization and DNA binding. Ro 41-5253 can inhibit cancer cell proliferation and induce apoptosis, has antitumor activity[1][2].

[Related Catalog]:

Signaling Pathways >> Apoptosis >> Apoptosis

Research Areas >> Cancer

Signaling Pathways >> Metabolic Enzyme/Protease >> RAR/RXR

[Target]

IC50: 60 nM (RARα), 2.4 μM (RARβ), 3.3 μM (RARγ)[3].

[In Vitro]

Ro 41-5253 (1 nM-10 μM, 10 days) significantly inhibits MCF-7 and ZR 75.1 cell proliferation and induces cell apoptosis in a time and dose-dependent manner[1]. Cell Proliferation Assay[1] Cell Line: Human breast-carcinoma lines MCF-7 and ZR 75.1 Concentration: 1 nM-10 μM Incubation Time: 10 days Result: Inhibited 81% MCF-7 cell growth at 10 μM, 30% cell growth at 1 μM and no significant inhibitory effect at concentrations below 0.1 μM. Inhibited 74% ZR 75.1 cell growth at 10 μM, 63% cell growth at 1 μM and 42% cell growth at 0.1 μM. Apoptosis Analysis[1] Cell Line: Human breast-carcinoma lines MCF-7 and ZR 75.1 Concentration: 1 nM-10 μM Incubation Time: 10 days Result: Induced 28.5, 21.6, 16 and 12% of MCF-7 cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively on the fourth day while induced 58, 51, 36 and 21% of cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively after six days. Induced 80, 65, 43 and 29% of ZR 75.1 cells apoptosis at 10 μM, 1 μM, 0.1 μM and 0.01 μM respectively on the sixth day.

[In Vivo]

Ro 41-5253 (oral gavage, 10-600 mg/kg, once a week, 4 weeks) can reduce tumor volume in female athymic Balb/mice transplanted with MCF-7 cell line[2]. Animal Model: Six-week-old female athymic Balb/mice transplanted with MCF-7 cell line[2] Dosage: 10, 30, 100, 300 and 600 mg/kg Administration: Oral gavage; once a week; 4 weeks Result: Resulted in a reduction in tumor volume at doses of 10, 30 and 100 mg/kg with no toxic side effects.

[References]

[1]. S Toma, et al. RARalpha antagonist Ro 41-5253 inhibits proliferation and induces apoptosis in breast-cancer cell lines. Int J Cancer. 1998 Sep 25;78(1):86-94

[2]. Salvatore Toma, et al. Retinoids and human breast cancer: in vivo effects of an antagonist for RAR-alpha. Cancer Lett. 2005 Feb 28;219(1):27-31. doi: 10.1016/j.canlet.2004.06.018.

[3]. C Apfel, et al. A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):7129-33.

Chemical & Physical Properties

[ Density]:
1.154g/cm3

[ Boiling Point ]:
661.4ºC at 760 mmHg

[ Molecular Formula ]:
C₂₈H₃₆O₅S

[ Molecular Weight ]:
484.64700

[ Flash Point ]:
353.8ºC

[ Exact Mass ]:
484.22800

[ PSA ]:
89.05000

[ LogP ]:
7.83030

[ Vapour Pressure ]:
2.16E-18mmHg at 25°C

[ Index of Refraction ]:
1.558

MSDS

Click to get detail MSDS

Safety Information

[ RIDADR ]:
NONH for all modes of transport

Articles

Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro.

Br. J. Nutr. 111(9) , 1586-93, (2014)

Our previous studies have shown that vitamin A (VA) status is associated with antiviral immunity and pathogenic conditions in enterovirus 71 (EV71)-infected children. In the present study, we establis...

Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice.

Immunology 126(4) , 514-22, (2009)

Interleukin-2 (IL-2) is an essential cytokine for T-lymphocyte homeostasis. We have previously reported that all-trans retinoic acid (atRA) enhances the secretion of IL-2 from human peripheral blood T...

Overexpression of mucin genes induced by interleukin-1 beta, tumor necrosis factor-alpha, lipopolysaccharide, and neutrophil elastase is inhibited by a retinoic acid receptor alpha antagonist.

Exp. Lung Res. 28(4) , 315-32, (2002)

Proinflammatory cytokines, lipopolysaccharide (LPS), and neutrophil elastase (NE) have been implicated in the induction of hypersecretion of respiratory mucus. In this study, we demonstrated that inte...

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.